The latest Eurostat data show Europe is not delivering on the Lisbon targets. So what is to be done, asks Bruno van Pottelsberghe from the think tank Bruegel.
DePuy Inc, the company that claims to have pioneered the hip replacement, is to set up an Innovation Centre with backing from the Irish Development Agency.
Commission Vice President Günter Verheugen is determined to repeat the GSM standard success story. To do so, the European Union must step in to help bring innovative products and services to market.
Speed – and staying close to the customer – is the key to commercialising new materials for electronics. But you can’t do this in Europe, says Thomas Geelhaar, head of R&D at Merck Chemicals.
An OECD conference highlights the hottest trend in corporate R&D. But take heed: in business or politics, beware too much success, says Richard L. Hudson.
Thomas Geelhaar, Head of Chemicals R&D at Merck in Darmstadt, Germany, describes how the company scouts for technologies and interacts with universities.
ITI Life Sciences, Scotland’s publicly funded innovation group, is to invest a further £2 million in its programme to develop new drug discovery tools.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.